Skip to main content
Erschienen in: Der Internist 2/2008

01.02.2008 | Schwerpunkt: Prävention in der Inneren Medizin

Prävention von Erkrankungen des Respirationstrakts

verfasst von: Prof. Dr. J.C. Virchow

Erschienen in: Die Innere Medizin | Ausgabe 2/2008

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Möglichkeiten der pulmonalen oder bronchialen Schädigungen sind mannigfaltig und übertreffen an Zahl andere, in diesem Heft bearbeitete Organsysteme. Durch diese Vielzahl der Erkrankungen, die zumindest partiell auf exogene Schädigungen zurückzuführen sind, ergeben sich aber auch mannigfaltige Ansätze zur Prävention. Die vorliegende Übersicht erhebt keinen Anspruch auf Vollständigkeit. Sie soll aber die Möglichkeiten verdeutlichen, die in der Prävention pulmonaler Erkrankungen bestehen. Sie soll aber auch aufzeigen, dass eine wirksame Primär-, und gelegentlich Sekundär- und Tertiärprävention in der Lungenheilkunde immer noch unzureichend oder gar nicht genutzt werden. Vor dem Hintergrund, dass präventive Maßnahmen auch in der Pneumologie individuell, aber auch aus Sicht der Gesundheitsökonomie, wesentlich erfolgreicher sind als Maßnahmen zur Kuration, sollen verschiedene Möglichkeiten erfolgreicher Prävention aufgezeigt werden. Darüber hinaus wird der große Bedarf an Studien zur Wirksamkeit präventiver Strategien erläutert.
Literatur
1.
Zurück zum Zitat Aristegui J, Bernaola E, Pocheville I et al. (2007) Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine. Eur J Clin Microbiol Infect Dis 26: 303–310PubMedCrossRef Aristegui J, Bernaola E, Pocheville I et al. (2007) Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine. Eur J Clin Microbiol Infect Dis 26: 303–310PubMedCrossRef
2.
Zurück zum Zitat Barone-Adesi F, Vizzini L, Merletti F, Richiardi L (2006) Short-term effects of Italian smoking regulation on rates of hospital admission for acute myocardial infarction. Eur Heart J 27: 2468–2472PubMedCrossRef Barone-Adesi F, Vizzini L, Merletti F, Richiardi L (2006) Short-term effects of Italian smoking regulation on rates of hospital admission for acute myocardial infarction. Eur Heart J 27: 2468–2472PubMedCrossRef
3.
Zurück zum Zitat Braun-Fahrlander C (2003) Environmental exposure to endotoxin and other microbial products and the decreased risk of childhood atopy: evaluating developments since April 2002. Curr Opin Allergy Clin Immunol 3: 325–329PubMedCrossRef Braun-Fahrlander C (2003) Environmental exposure to endotoxin and other microbial products and the decreased risk of childhood atopy: evaluating developments since April 2002. Curr Opin Allergy Clin Immunol 3: 325–329PubMedCrossRef
4.
Zurück zum Zitat Calverley PM, Anderson JA, Celli B et al. (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356: 775–789PubMedCrossRef Calverley PM, Anderson JA, Celli B et al. (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 356: 775–789PubMedCrossRef
5.
Zurück zum Zitat Casaburi R, Kukafka D, Cooper CB et al. (2005) Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 127: 809–817PubMedCrossRef Casaburi R, Kukafka D, Cooper CB et al. (2005) Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 127: 809–817PubMedCrossRef
6.
Zurück zum Zitat Casaburi R, Mahler DA, Jones PW et al. (2002) A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 19: 217–224PubMedCrossRef Casaburi R, Mahler DA, Jones PW et al. (2002) A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 19: 217–224PubMedCrossRef
7.
Zurück zum Zitat Chandran A, Watt JP, Santosham M (2005) Prevention of Haemophilus influenzae type b disease: past success and future challenges. Expert Rev Vaccines 4: 819–827PubMedCrossRef Chandran A, Watt JP, Santosham M (2005) Prevention of Haemophilus influenzae type b disease: past success and future challenges. Expert Rev Vaccines 4: 819–827PubMedCrossRef
8.
Zurück zum Zitat Churchyard GJ, Scano F, Grant AD, Chaisson RE (2007) Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities. J Infect Dis (Suppl 1) 196: S52–S62 Churchyard GJ, Scano F, Grant AD, Chaisson RE (2007) Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities. J Infect Dis (Suppl 1) 196: S52–S62
9.
Zurück zum Zitat Ciofi Degli Atti ML, Filia A, Massari M et al. (2006) Assessment of measles incidence, measles-related complications and hospitalisations during an outbreak in a southern Italian region. Vaccine 24: 1332–1338CrossRef Ciofi Degli Atti ML, Filia A, Massari M et al. (2006) Assessment of measles incidence, measles-related complications and hospitalisations during an outbreak in a southern Italian region. Vaccine 24: 1332–1338CrossRef
10.
Zurück zum Zitat Claes C, Schulenburg JM Graf von der (2003) Cost effectiveness of pneumococcal vaccination for infants and children with the conjugate vaccine PnC-7 in Germany. Pharmacoeconomics 21: 587–600PubMedCrossRef Claes C, Schulenburg JM Graf von der (2003) Cost effectiveness of pneumococcal vaccination for infants and children with the conjugate vaccine PnC-7 in Germany. Pharmacoeconomics 21: 587–600PubMedCrossRef
11.
Zurück zum Zitat Doll R, Peto R, Wheatley K et al. (1994) Mortality in relation to smoking: 40 years‘ observations on male British doctors. BMJ 309: 901–911PubMed Doll R, Peto R, Wheatley K et al. (1994) Mortality in relation to smoking: 40 years‘ observations on male British doctors. BMJ 309: 901–911PubMed
12.
Zurück zum Zitat Ellerbeck EF, Ahluwalia JS, Jolicoeur DG et al. (2001) Direct observation of smoking cessation activities in primary care practice. J Fam Pract 50: 688–693PubMed Ellerbeck EF, Ahluwalia JS, Jolicoeur DG et al. (2001) Direct observation of smoking cessation activities in primary care practice. J Fam Pract 50: 688–693PubMed
13.
Zurück zum Zitat Filia A, Brenna A, Pana A et al. (2007) Health burden and economic impact of measles-related hospitalizations in Italy in 2002–2003. BMC Public Health 7: 169PubMedCrossRef Filia A, Brenna A, Pana A et al. (2007) Health burden and economic impact of measles-related hospitalizations in Italy in 2002–2003. BMC Public Health 7: 169PubMedCrossRef
14.
Zurück zum Zitat Fisman DN, Abrutyn E, Spaude KA et al. (2006) Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis 42: 1093–1101PubMedCrossRef Fisman DN, Abrutyn E, Spaude KA et al. (2006) Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis 42: 1093–1101PubMedCrossRef
15.
Zurück zum Zitat Fitzpatrick TM, Blair EA (2000) Upper airway complications of smoking. Clin Chest Med 21: 147–157, xPubMedCrossRef Fitzpatrick TM, Blair EA (2000) Upper airway complications of smoking. Clin Chest Med 21: 147–157, xPubMedCrossRef
16.
Zurück zum Zitat Garwood CL, Potts LA (2007) Emerging pharmacotherapies for smoking cessation. Am J Health Syst Pharm 64: 1693–1698PubMedCrossRef Garwood CL, Potts LA (2007) Emerging pharmacotherapies for smoking cessation. Am J Health Syst Pharm 64: 1693–1698PubMedCrossRef
17.
Zurück zum Zitat Grijalva CG, Nuorti JP, Arbogast PG et al. (2007) Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 369: 1179–1186PubMedCrossRef Grijalva CG, Nuorti JP, Arbogast PG et al. (2007) Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 369: 1179–1186PubMedCrossRef
18.
Zurück zum Zitat Heinrich J, Slama R (2007) Fine particles, a major threat to children. Int J Hyg Environ Health 210: 617–622PubMedCrossRef Heinrich J, Slama R (2007) Fine particles, a major threat to children. Int J Hyg Environ Health 210: 617–622PubMedCrossRef
19.
Zurück zum Zitat Horsburgh CR (2004) Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 350: 2060–2067PubMedCrossRef Horsburgh CR (2004) Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 350: 2060–2067PubMedCrossRef
20.
Zurück zum Zitat Hurt RD, Ebbert JO (2002) Preventing lung cancer by stopping smoking. Clin Chest Med 23: 27–36, viiPubMedCrossRef Hurt RD, Ebbert JO (2002) Preventing lung cancer by stopping smoking. Clin Chest Med 23: 27–36, viiPubMedCrossRef
21.
Zurück zum Zitat Hurt RD, Sachs DP, Glover ED et al. (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 337: 1195–1202PubMedCrossRef Hurt RD, Sachs DP, Glover ED et al. (1997) A comparison of sustained-release bupropion and placebo for smoking cessation. N Engl J Med 337: 1195–1202PubMedCrossRef
22.
Zurück zum Zitat Joad JP (2000) Smoking and pediatric respiratory health. Clin Chest Med 21: 37–46, vii–viiiPubMedCrossRef Joad JP (2000) Smoking and pediatric respiratory health. Clin Chest Med 21: 37–46, vii–viiiPubMedCrossRef
23.
Zurück zum Zitat Johnstone J, Marrie TJ, Eurich DT, Majumdar SR (2007) Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia. Arch Intern Med 167: 1938–1943PubMedCrossRef Johnstone J, Marrie TJ, Eurich DT, Majumdar SR (2007) Effect of pneumococcal vaccination in hospitalized adults with community-acquired pneumonia. Arch Intern Med 167: 1938–1943PubMedCrossRef
24.
Zurück zum Zitat Kumra V, Markoff BA (2000) Who’s smoking now? The epidemiology of tobacco use in the United States and abroad. Clin Chest Med 21: 1–9, viiPubMedCrossRef Kumra V, Markoff BA (2000) Who’s smoking now? The epidemiology of tobacco use in the United States and abroad. Clin Chest Med 21: 1–9, viiPubMedCrossRef
25.
Zurück zum Zitat Lacasse Y, Goldstein R, Lasserson TJ, Martin S (2006) Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 4: CD003793PubMed Lacasse Y, Goldstein R, Lasserson TJ, Martin S (2006) Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 4: CD003793PubMed
26.
Zurück zum Zitat MacNee W, Donaldson K (2000) Exacerbations of COPD: environmental mechanisms. Chest 117: 390S–397SPubMedCrossRef MacNee W, Donaldson K (2000) Exacerbations of COPD: environmental mechanisms. Chest 117: 390S–397SPubMedCrossRef
27.
Zurück zum Zitat Martin C (2006) Tuberculosis vaccines: past, present and future. Curr Opin Pulm Med 12: 186–191PubMedCrossRef Martin C (2006) Tuberculosis vaccines: past, present and future. Curr Opin Pulm Med 12: 186–191PubMedCrossRef
28.
Zurück zum Zitat Niggemann B, Jacobsen L, Dreborg S et al. (2006) Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children. Allergy 61: 855–859PubMedCrossRef Niggemann B, Jacobsen L, Dreborg S et al. (2006) Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children. Allergy 61: 855–859PubMedCrossRef
29.
Zurück zum Zitat O’Donnell DE, Sciurba F, Celli B et al. (2006) Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest 130: 647–656CrossRef O’Donnell DE, Sciurba F, Celli B et al. (2006) Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. Chest 130: 647–656CrossRef
30.
Zurück zum Zitat Percival J (2007) Smoking: tackling the silent epidemic. J Fam Health Care 17: 109–110PubMed Percival J (2007) Smoking: tackling the silent epidemic. J Fam Health Care 17: 109–110PubMed
31.
Zurück zum Zitat Potts LA, Garwood CL (2007) Varenicline: the newest agent for smoking cessation. Am J Health Syst Pharm 64: 1381–1384PubMedCrossRef Potts LA, Garwood CL (2007) Varenicline: the newest agent for smoking cessation. Am J Health Syst Pharm 64: 1381–1384PubMedCrossRef
32.
Zurück zum Zitat Rose MA, Schubert R, Kujumdshiev S et al. (2006) Immunoglobulins and immunogenicity of pneumococcal vaccination in preschool asthma. Int J Clin Pract 60: 1425–1431PubMedCrossRef Rose MA, Schubert R, Kujumdshiev S et al. (2006) Immunoglobulins and immunogenicity of pneumococcal vaccination in preschool asthma. Int J Clin Pract 60: 1425–1431PubMedCrossRef
33.
Zurück zum Zitat Silagy C, Lancaster T, Stead L et al. (2004) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 3: CD000146PubMed Silagy C, Lancaster T, Stead L et al. (2004) Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 3: CD000146PubMed
34.
Zurück zum Zitat Tanoue LT (2000) Cigarette smoking and women’s respiratory health. Clin Chest Med 21: 47–65PubMedCrossRef Tanoue LT (2000) Cigarette smoking and women’s respiratory health. Clin Chest Med 21: 47–65PubMedCrossRef
35.
Zurück zum Zitat Vincken W, Noord JA van, Greefhorst AP et al. (2002) Improved health outcomes in patients with COPD during 1 yr’s treatment with tiotropium. Eur Respir J 19: 209–216PubMedCrossRef Vincken W, Noord JA van, Greefhorst AP et al. (2002) Improved health outcomes in patients with COPD during 1 yr’s treatment with tiotropium. Eur Respir J 19: 209–216PubMedCrossRef
36.
Zurück zum Zitat Wedzicha JA, Calverley PM, Seemungal TA et al. (2007) The prevention of COPD exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med [Epub ahead of print] Wedzicha JA, Calverley PM, Seemungal TA et al. (2007) The prevention of COPD exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med [Epub ahead of print]
37.
Zurück zum Zitat Wills-Karp M, Brandt D, Morrow AL (2004) Understanding the origin of asthma and its relationship to breastfeeding. Adv Exp Med Biol 554: 171–191PubMed Wills-Karp M, Brandt D, Morrow AL (2004) Understanding the origin of asthma and its relationship to breastfeeding. Adv Exp Med Biol 554: 171–191PubMed
38.
Zurück zum Zitat Wisloff T, Abrahamsen TG, Bergsaker MA et al. (2006) Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program. Vaccine 24: 5690–5699PubMedCrossRef Wisloff T, Abrahamsen TG, Bergsaker MA et al. (2006) Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program. Vaccine 24: 5690–5699PubMedCrossRef
Metadaten
Titel
Prävention von Erkrankungen des Respirationstrakts
verfasst von
Prof. Dr. J.C. Virchow
Publikationsdatum
01.02.2008
Verlag
Springer-Verlag
Erschienen in
Die Innere Medizin / Ausgabe 2/2008
Print ISSN: 2731-7080
Elektronische ISSN: 2731-7099
DOI
https://doi.org/10.1007/s00108-007-1997-4

Weitere Artikel der Ausgabe 2/2008

Der Internist 2/2008 Zur Ausgabe

CME Weiterbildung • Zertifizierte Fortbildung

Synkope

Schwerpunkt: Prävention in der Inneren Medizin

Prävention von Malignomen des Verdauungstrakts

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.